Layoff
Announces layoffs
Boston biotech EveryONE Medicines, which developed individualized therapies for ultra-rare genetic diseases, is shutting down, Endpoints News reported. An anonymous source tied the closure to difficulties with the FDA's new bespoke-therapy framework; the company declined to comment.



